The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion (Q24297013)

positive regulation of cell migration

GOA release 2020-03-11

1 reference

European Journal of Cancer

GOA release 2020-03-11

1 reference

Sze Ki Luk

1

0 references

Roland P Piekorz

series ordinal

2

0 references

Bernd Nürnberg

series ordinal

3

0 references

Shing-Shun Tony To

series ordinal

4

0 references

language of work or name

English

0 references

publication date

January 2012

0 references

published in

0 references

volume

48

0 references

issue

1

0 references

page(s)

149-57

0 references

cites work

Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Targeting phosphoinositide 3-kinase: moving towards therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Mutant PIK3CA promotes cell growth and invasion of human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Cdc42 in oncogenic transformation, invasion, and tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Rho GTPases in cancer cell biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Inhibitors of phosphatidylinositol-3-kinase in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Molecular switches in metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Role of integrins in cell invasion and migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Class I PI3K in oncogenic cellular transformation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Exploring the specificity of the PI3K family inhibitor LY294002.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Signalling through Class I PI3Ks in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

p110δ, a novel phosphoinositide 3-kinase in leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

IQGAP1 promotes cell motility and invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

FAK signaling in anaplastic astrocytoma and glioblastoma tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Synthesis and function of 3-phosphorylated inositol lipids

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Essential role for the p110 isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Glioblastoma multiforme: a review of where we have been and where we are going

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Role of Rho GTPases and their regulators in cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021

PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCA.2011.09.006

7 January 2021